FKYS, the Pennsylvania-based community lender, has spent the past week drifting quietly lower — but the more interesting story is what insiders have been doing with the stock and how the borrowing market has quietly tightened around it.
The stock closed Wednesday at $18.91, off just 0.4% on the day and down less than half a percent on the week. The month is a different picture: FKYS is up roughly 0.7% in April, a modest positive backdrop for a micro-cap bank trading on the OTC pink sheets with a market cap near $120 million. There are no upcoming earnings on the calendar, with the company having filed amended Q4 2025 results in late March — a print that produced a one-day gain of nearly 4% and held most of those gains over the following five sessions.
The clearest signal worth flagging this week is the persistent insider buying pattern. Every disclosed transaction in the record is a purchase. The most recent was the CEO, Jack W. Jones, picking up 974 shares at $18.43 in late December — a small dollar figure at roughly $18,000, but notable because it follows a consistent thread. The Chairman of the Board added 3,022 shares at $15.00 last May. A director added 1,886 shares across two trades in February 2025 at around $14.10. The COO bought in August. Not one insider sale appears in the record. That kind of uniform buying across the C-suite and board, even in small size, signals comfort with the price level and alignment with common shareholders.
The lending market around FKYS is not stressed, but it is gradually tightening. Cost to borrow has climbed steadily from roughly 2.5% at the start of the year to just under 5% now — nearly doubling in four months. That move is consistent with a slow increase in demand for borrows rather than a sudden squeeze. Availability remains untracked at a granular level here, but lending utilisation has been erratic, hitting zero on several sessions in March and early April before jumping back to roughly 22% this week. The short interest itself is negligible — just 0.18% of the free float — so there is no meaningful short side story here. The rising borrow cost is a curiosity, not a catalyst.
The ORTEX short score of 36, sitting near the bottom third of the universe, reflects the benign short-side picture. Days to cover ranks in the 86th percentile, a function of thin daily volume rather than concentrated short positioning. The dividend score of 43 is middling, and the most recent dividend information in the data dates to early 2022 — though the company announced a Q1 dividend in late March 2026, suggesting the payout has been maintained through the intervening period. Valuation multiples are not available from current data, and no analyst coverage is visible on this name, consistent with its size and OTC listing.
What to watch next: the annual meeting proxy, filed in early April for a May 21 date, will be the next formal governance event. With borrow costs continuing their four-month grind higher and no analyst coverage to set a narrative, price direction here will likely be driven by any change in the insider buying cadence or by broader community-banking sentiment as regional rate dynamics evolve.
See the live data behind this article on ORTEX.
Open FKYS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
